Hormonal replacement therapy may reduce risk of colorectal cancer
نویسندگان
چکیده
منابع مشابه
[Hormonal replacement therapy and breast cancer].
The recent publication of some randomised control trials results and of two important cohort studies makes possible a better understanding of the relation between hormonal replacement therapy (HRT) and breast cancer. It is now well established that estrogen-progestin replacement therapy is associated with an elevation of breast cancer risk. It is not possible to define duration of treatment wit...
متن کاملDo statins and hormonal replacement therapy in combination reduce cardiovascular risk in postmenopausal women?
[1] Elizari MV, Martı́nez JM, Belziti C et al. Morbidity and mortality following early administration of amiodarone in acute myocardial infarction. Eur Heart J 2000; 21: 198–205. [2] Burkart F, Pfisterer M, Kiowski W, Follath F, Burckhardt D. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic...
متن کاملAromatase inhibitors may reduce endometrial cancer risk.
Use of aromatase inhibitors, which are known to reduce endogenous oestrogen levels, as adjuvant therapy had a lower risk of endometrial cancer, compared with that of patients who were treated with tamoxifen, results of a new study show. In this study, Rowan Chleblowski and colleagues (Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Los Angeles, CA, USA) examined the rec...
متن کاملProgestogens and breast cancer risk: the role of hormonal contraceptives and hormone replacement therapy.
Journal of Family Planning and Reproductive Health Care 2003: 29(4) Most breast cancers are oestrogen-dependent. In addition, large randomised trials have demonstrated improved survival for women with hormone-sensitive disease given treatment that reduces the synthesis or activity of endogenous oestrogen.1 This level of clinical evidence, and the fact that early menarche and delayed menopause a...
متن کاملProgestogens and breast cancer risk: the role of hormonal contraceptives and hormone replacement therapy
Journal of Family Planning and Reproductive Health Care 2003: 29(4) Most breast cancers are oestrogen-dependent. In addition, large randomised trials have demonstrated improved survival for women with hormone-sensitive disease given treatment that reduces the synthesis or activity of endogenous oestrogen.1 This level of clinical evidence, and the fact that early menarche and delayed menopause a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Reactions Weekly
سال: 2021
ISSN: ['1179-2051', '0114-9954']
DOI: https://doi.org/10.1007/s40278-021-94871-3